134 related articles for article (PubMed ID: 31809313)
1. TTF1-positive Papillary Epithelial Tumor of Pituitary: An Epithelial Variant of Pituicytoma?
Chatterjee D; Lath K; Radotra BD; Gupta AK; Singh P
Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):e1-e5. PubMed ID: 31809313
[TBL] [Abstract][Full Text] [Related]
2. Epithelial and organ-related marker expression in pituitary adenomas.
Cykowski MD; Takei H; Baskin DS; Rivera AL; Powell SZ
Neuropathology; 2016 Aug; 36(4):354-64. PubMed ID: 26991787
[TBL] [Abstract][Full Text] [Related]
3. Primary papillary epithelial tumour of the sella: expanding the spectrum of TTF-1-positive sellar lesions.
Roncaroli F; Chatterjee D; Giannini C; Pereira M; La Rosa S; Brouland JP; Gnanalingham K; Galli C; Fernandes B; Lania A; Radotra B
Neuropathol Appl Neurobiol; 2020 Aug; 46(5):493-505. PubMed ID: 32311761
[TBL] [Abstract][Full Text] [Related]
4. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
Tan A; Etit D; Bayol U; Altinel D; Tan S
Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
[TBL] [Abstract][Full Text] [Related]
5. Pituicytoma.
Kowalski RJ; Prayson RA; Mayberg MR
Ann Diagn Pathol; 2004 Oct; 8(5):290-4. PubMed ID: 15494936
[TBL] [Abstract][Full Text] [Related]
6. Pituicytoma with unusual histological features.
Kwon MJ; Suh YL
Pathol Int; 2011 Oct; 61(10):598-602. PubMed ID: 21951670
[TBL] [Abstract][Full Text] [Related]
7. Expression of thyroid transcription factor-1 and other markers in sclerosing hemangioma of the lung.
Illei PB; Rosai J; Klimstra DS
Arch Pathol Lab Med; 2001 Oct; 125(10):1335-9. PubMed ID: 11570910
[TBL] [Abstract][Full Text] [Related]
8. Pituicytoma-An outlook on possible targeted therapies.
Mende KC; Matschke J; Burkhardt T; Saeger W; Buslei R; Buchfelder M; Fahlbusch R; Westphal M; Flitsch J
CNS Neurosci Ther; 2017 Jul; 23(7):620-626. PubMed ID: 28556544
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathological features of pituicytoma and the differential diagnosis of sellar glioma.
Wang J; Liu Z; Du J; Cui Y; Fang J; Xu L; Li G
Neuropathology; 2016 Oct; 36(5):432-440. PubMed ID: 26919073
[TBL] [Abstract][Full Text] [Related]
10. TTF-1-positive oncocytic sellar tumor with follicle formation/ependymal differentiation: non-adenomatous tumor capable of two different interpretations as a pituicytoma or a spindle cell oncocytoma.
Yoshimoto T; Takahashi-Fujigasaki J; Inoshita N; Fukuhara N; Nishioka H; Yamada S
Brain Tumor Pathol; 2015 Jul; 32(3):221-7. PubMed ID: 25893822
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Features of Low-Grade Thyroid-like Nasopharyngeal Papillary Adenocarcinoma.
Li M; Wei J; Yao X; Wang C
Cancer Res Treat; 2017 Jan; 49(1):213-218. PubMed ID: 27384157
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: identified by immunohistochemical and ultrastructural study.
Xu HM; Li WH; Hou N; Zhang SG; Li HF; Wang SQ; Yu ZY; Li ZJ; Zeng MY; Zhu GM
Am J Surg Pathol; 1997 Sep; 21(9):1013-22. PubMed ID: 9298877
[TBL] [Abstract][Full Text] [Related]
13. Is spindle cell oncocytoma a true entity or a variant of pituicytoma? A case report with review of literature.
Gupta RK; Batra VV; Singh D; Sharma MC; Kumar V
Neurol India; 2018; 66(5):1413-1418. PubMed ID: 30233016
[TBL] [Abstract][Full Text] [Related]
14. [Non-functioning pituitary adenomas: clinical features and immunohistochemistry].
Ferreira JE; de Mello PA; de Magalhães AV; Botelho CH; Naves LA; Nosé V; Schmitt F
Arq Neuropsiquiatr; 2005 Dec; 63(4):1070-8. PubMed ID: 16400431
[TBL] [Abstract][Full Text] [Related]
15. Synchronous pituitary adenoma and pituicytoma.
Neidert MC; Leske H; Burkhardt JK; Kollias SS; Capper D; Schrimpf D; Regli L; Rushing EJ
Hum Pathol; 2016 Jan; 47(1):138-43. PubMed ID: 26476569
[TBL] [Abstract][Full Text] [Related]
16. Immunoprofiling of glial tumours of the neurohypophysis suggests a common pituicytic origin of neoplastic cells.
Hagel C; Buslei R; Buchfelder M; Fahlbusch R; Bergmann M; Giese A; Flitsch J; Lüdecke DK; Glatzel M; Saeger W
Pituitary; 2017 Apr; 20(2):211-217. PubMed ID: 27744503
[TBL] [Abstract][Full Text] [Related]
17. Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study.
Ramírez C; Cheng S; Vargas G; Asa SL; Ezzat S; González B; Cabrera L; Guinto G; Mercado M
J Clin Endocrinol Metab; 2012 May; 97(5):1745-51. PubMed ID: 22419713
[TBL] [Abstract][Full Text] [Related]
18. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.
Kenny SL; McBride HA; Jamison J; McCluggage WG
Am J Surg Pathol; 2012 Jun; 36(6):799-807. PubMed ID: 22456609
[TBL] [Abstract][Full Text] [Related]
19. Correlations between clinical hormone change and pathological features of pituicytoma.
Chang TW; Lee CY; Jung SM; Lai HY; Chen CT; Yeap MC; Chuang CC; Hsu PW; Chang CN; Tu PH; Lee ST
Br J Neurosurg; 2018 Oct; 32(5):501-508. PubMed ID: 29749277
[TBL] [Abstract][Full Text] [Related]
20. A rare case report of pituicytoma with biphasic pattern and admixed with scattered Herring bodies.
Cao Y; Zeng Y; Qin X; Tan Y; Zeng M; Wang L; Cao X; Zou L; Wang C
World J Surg Oncol; 2020 May; 18(1):108. PubMed ID: 32460843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
